Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Gastrointestinal Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07358884
What this trial is testing

First in Human Study of QLS5316 in Solid Tumors

Who this might be right for
Solid TumorsColorectal CancerGastric Cancer or Gastroesophageal Junction Adenocarcinoma+2 more
Qilu Pharmaceutical Co., Ltd. 300
Testing effectiveness (Phase 2)UnknownNCT02602938
What this trial is testing

Aspirin on CTCs of Advanced Breast and Colorectal Cancer

Who this might be right for
Epithelial-Mesenchymal TransitionCirculating Tumor Cells
Zhejiang Provincial People's Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00201838
What this trial is testing

Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic NeoplasmsAdenocarcinoma
Ohio State University Comprehensive Cancer Center 38
Large-scale testing (Phase 3)UnknownNCT03598348
What this trial is testing

Evaluate the Efficacy of Maintenance Treatment With Capecitabine Plus Apatinib in Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Huazhong University of Science and Technology 288
Large-scale testing (Phase 3)UnknownNCT04426955
What this trial is testing

Study of Camrelizumab (SHR-1210) in Combination With Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
Jiangsu HengRui Medicine Co., Ltd. 396
Testing effectiveness (Phase 2)UnknownNCT05426811
What this trial is testing

Regorafenib Plus Raltitrexed as Third-line Treatment in Advanced Colorectal Cancer Patients

Who this might be right for
RegorafenibRaltitrexedColorectal Neoplasms+1 more
China Medical University, China 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06014944
What this trial is testing

Short-course Radiotherapy Combined With Furoquintinib and PD-1 Monoclonal Antibody

Who this might be right for
Rectal Cancer
Changhai Hospital 30
Testing effectiveness (Phase 2)UnknownNCT04443309
What this trial is testing

Lenvatinib in Combination With Camrelizumab as First-Line Therapy in Patients With Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Peking Union Medical College Hospital 53
Testing effectiveness (Phase 2)Study completedNCT04072198
What this trial is testing

Nivolumab Plus FOLFOXIRI/Bevacizumab in First Line Chemotherapy of Advanced Colorectal Cancer RASm/BRAFm Patients

Who this might be right for
Colorectal Cancer
Gruppo Oncologico Italiano di Ricerca Clinica 73
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07773363
What this trial is testing

Retlirafusp Alfa Plus Apatinib and Chemotherapy as Second-Line Treatment for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Tang-Du Hospital 37
Early research (Phase 1)Active Not RecruitingNCT03264664
What this trial is testing

Study of E7386 in Participants With Selected Advanced Neoplasms

Who this might be right for
Advanced Neoplasms
Eisai Inc. 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06724263
What this trial is testing

A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors

Who this might be right for
Recurrent Platinum-resistant Epithelial Ovarian CancerTriple Negative Breast Cancer (TNBC)Cervical Cancers+4 more
Tasly Biopharmaceuticals Co., Ltd. 120
Not applicableStudy completedNCT05197504
What this trial is testing

Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Systemic Therapy

Who this might be right for
Hepatocellular Carcinoma
CHA University 166
Testing effectiveness (Phase 2)Active Not RecruitingNCT03785249
What this trial is testing

Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1

Who this might be right for
Advanced CancerMetastatic CancerMalignant Neoplastic Disease
Mirati Therapeutics Inc. 731
Early research (Phase 1)Looking for participantsNCT04806464
What this trial is testing

Clinical Study of VG161 in Subjects with Advanced Primary Liver Cancer

Who this might be right for
Primary Liver Cancer
CNBG-Virogin Biotech (Shanghai) Ltd. 44
Not applicableLooking for participantsNCT07225309
What this trial is testing

Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

Who this might be right for
Breast CancerProstate CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center 300
Testing effectiveness (Phase 2)UnknownNCT05322499
What this trial is testing

Phase II Clinical Study of Camrelizumab Combined With Chemotherapy or Anlotinib in Advanced Esophageal Squamous Cell Cancer

Who this might be right for
Stage IV Esophagus Squamous Cell Carcinoma
Zhejiang Cancer Hospital 80
Large-scale testing (Phase 3)Looking for participantsNCT06949033
What this trial is testing

Neoadjuvant Cadonilimab Combined With Perioperative Oxaliplatin Plus S1 for Diffuse or Mixed Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])Neoadjuvant TherapyAdjuvant Chemotherapy+3 more
Zuoyi Jiao 668
Not applicableNo Longer AvailableNCT04137822
What this trial is testing

Expanded Access Program Using IMM-101 for Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreas CancerPancreatic CancerPancreatic Cancer Stage IV+1 more
Impatients N.V. trading as myTomorrows
Testing effectiveness (Phase 2)Study completedNCT02723253
What this trial is testing

Concurrent Chemoradiation With Concomitant Boost In Locally Advanced Rectal Cancer

Who this might be right for
Rectal Neoplasms
IRCCS Azienda Ospedaliero-Universitaria di Bologna 18
Next Page